Detalles de la búsqueda
1.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(1): 59-68, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331154
2.
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.
Lancet Oncol
; 14(1): 38-47, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23200175
3.
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
Lancet
; 374(9699): 1432-40, 2009 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-19767093
4.
Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
Lung Cancer
; 53(2): 171-6, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16757059
5.
Do Current Lung Cancer Screening Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the First Brazilian Lung Cancer Screening Trial (BRELT1).
Ann Thorac Surg
; 101(2): 481-6; discussion 487-8, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26409711
6.
Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions.
Chest
; 128(2): 684-9, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16100154
7.
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial.
Target Oncol
; 10(2): 255-65, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25195590
8.
Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).
BMC Cancer
; 4: 69, 2004 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-15456520
9.
Elderly subset analysis of randomized phase III study comparing pemetrexed plus carboplatin with docetaxel plus carboplatin as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer.
Drugs R D
; 13(4): 289-96, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24277116
10.
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.
J Clin Oncol
; 31(23): 2849-53, 2013 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23775961
11.
Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy.
J Thorac Oncol
; 7(6): 1041-8, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22534814
12.
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
J Thorac Oncol
; 7(12): 1823-1829, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23154554
13.
Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer.
Rev Assoc Med Bras (1992)
; 57(6): 686-91, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22249550
14.
Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer.
J Clin Oncol
; 28(11): 1835-42, 2010 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20212250
15.
Low-dose CT screening for lung cancer in Brazil: a study protocol.
J Bras Pneumol
; 40(2): 196-9, 2014.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-24831407
16.
Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer.
J Thorac Oncol
; 3(1): 30-6, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18166838
17.
Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
J Clin Oncol
; 26(11): 1886-92, 2008 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18398154
18.
Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer / Quimioterapia em câncer de pulmão não pequenas células metastático estádio IV: além da primeira linha
Rev. Assoc. Med. Bras. (1992)
; 57(6): 686-691, nov.-dez. 2011. ilus, tab
Artículo
en Inglés
| LILACS | ID: lil-611230
19.
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
J Clin Oncol
; 24(31): 5034-42, 2006 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17075123
20.
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
Lancet Oncol
; 7(9): 719-27, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16945766